Kalkan Ucar, Sema <br/><br/>
The first use of N-carbamylglutamate in a patient with decompensated maple syrup urine disease.  [electronic resource] 

 -  Metabolic brain disease  Sep 2009 
 - 409-14 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1573-7365 
<br/><br/><label>Standard No.: </label>10.1007/s11011-009-9155-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acidosis--blood<br/>Ammonia--blood<br/>Brain--pathology<br/>Child, Preschool<br/>Consanguinity<br/>Female<br/>Glutamates--therapeutic use<br/>Humans<br/>Infant, Newborn<br/>Leucine--blood<br/>Magnetic Resonance Imaging<br/>Maple Syrup Urine Disease--drug therapy